{"schema":"rootz.ai/filing-signals/v1","query":{"ticker":"EVH","limit":50},"count":50,"signals":[{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"ai_adoption","strength":100,"match_count":21,"context":"on, we have invested a significant amount in expanding our offerings. In connection with the Machinify acquisition, the Company has sought to further enhance and accelerate its uses of AI through its AI-enabled tools, such as Auth Intelligence. The Auth Intelligence tool incorporates AI to aid nurses and physicians in completing clinical review of prior authorization requests. Specifically, the tool identifies r","filed_date":"2026-02-25","accession":"0001628908-26-000015","full_text":"https://origin.rootz.global/static/filing/0001628908-26-000015.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"margin_pressure","strength":100,"match_count":17,"context":"entrance or expansion of these larger companies in the managed healthcare industry (including our customers who have in-sourced or who may choose to in-source healthcare services) could increase the competitive pressures we face and could limit our ability to maintain or increase our rates. If this happens, our profitability could be adversely affected. In addition, if we do not adequately respond to these competiti","filed_date":"2026-02-25","accession":"0001628908-26-000015","full_text":"https://origin.rootz.global/static/filing/0001628908-26-000015.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":90,"context":"unable to obtain, maintain and enforce the intellectual property rights on which our business depends, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. For additional information related to our intellectual property position see Part I - Item 1A. Risk Factors - Risks relating to Data Pr","filed_date":"2026-02-25","accession":"0001628908-26-000015","full_text":"https://origin.rootz.global/static/filing/0001628908-26-000015.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":24,"context":"the Compensation Committees most recent review, the Compensation Committee determined that the risks arising from the Companys compensation policies and practices are not reasonably likely to have a material adverse effect on the Company.  |  | |  42 |  |  Evolent Health, Inc. Proxy Statement 2025 |  |  | | [Table of Contents](#toc) COMPENSATION COMMITTEE REPORT  The Compensation Committee has reviewed and discussed th","filed_date":"2025-04-25","accession":"0001193125-25-096749","full_text":"https://origin.rootz.global/static/filing/0001193125-25-096749.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"strategic_event","strength":100,"match_count":22,"context":"|  To ratify the appointment of Deloitte& Touche LLP as our independent registered public accounting firm for the fiscal year ending December31, 2025; | | |  3. |  To approve the compensation of our named executive officers for 2024 on an advisory basis; and | | |  4. |  To approve an amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan. | | In addition, stockholders may be asked to consider a","filed_date":"2025-04-25","accession":"0001193125-25-096749","full_text":"https://origin.rootz.global/static/filing/0001193125-25-096749.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"ai_adoption","strength":100,"match_count":26,"context":"on, we have invested a significant amount in expanding our offerings. In connection with the Machinify acquisition, the Company has sought to further enhance and accelerate its uses of AI through its AI-enabled tools, such as Auth Intelligence. The Auth Intelligence tool incorporates AI to aid nurses and physicians in completing clinical review of prior authorization requests. Specifically, the tool identifies r","filed_date":"2025-02-21","accession":"0001628908-25-000020","full_text":"https://origin.rootz.global/static/filing/0001628908-25-000020.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"margin_pressure","strength":100,"match_count":17,"context":"entrance or expansion of these larger companies in the managed healthcare industry (including our customers who have in-sourced or who may choose to in-source healthcare services) could increase the competitive pressures we face and could limit our ability to maintain or increase our rates. If this happens, our profitability could be adversely affected. In addition, if we do not adequately respond to these competiti","filed_date":"2025-02-21","accession":"0001628908-25-000020","full_text":"https://origin.rootz.global/static/filing/0001628908-25-000020.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":88,"context":"unable to obtain, maintain and enforce the intellectual property rights on which our business depends, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. For additional information related to our intellectual property position see Part I - Item 1A. Risk Factors - Risks relating to Data Pr","filed_date":"2025-02-21","accession":"0001628908-25-000020","full_text":"https://origin.rootz.global/static/filing/0001628908-25-000020.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":50,"context":"a41d081109d2c70835354_719)Investment Company Act83 [Section 7.08](#i84aadc1c02fa41d081109d2c70835354_714)Full Disclosure83 [Section 7.09](#i84aadc1c02fa41d081109d2c70835354_709)Financial Condition No Material Adverse Effect83 [Section 7.10](#i84aadc1c02fa41d081109d2c70835354_704)Tax Returns and Payments84 [Section 7.11](#i84aadc1c02fa41d081109d2c70835354_699)Compliance with ERISA84 [Section 7.12](#i84aadc1c02fa41d081109","filed_date":"2024-12-11","accession":"0001628908-24-000117","full_text":"https://origin.rootz.global/static/filing/0001628908-24-000117.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":24,"context":"the Compensation Committees most recent review, the Compensation Committee determined that the risks arising from the Companys compensation policies and practices are not reasonably likely to have a material adverse effect on the Company.  |  | |  |  |  Evolent Health, Inc. Proxy Statement 2024 |  |  |  43 |  | | [Table of Contents](#toc) COMPENSATION COMMITTEE REPORT  The Compensation Committee has reviewed and discus","filed_date":"2024-04-26","accession":"0001193125-24-118116","full_text":"https://origin.rootz.global/static/filing/0001193125-24-118116.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"strategic_event","strength":100,"match_count":23,"context":"|  To ratify the appointment of Deloitte& Touche LLP as our independent registered public accounting firm for the fiscal year ending December31, 2024; | | |  3. |  To approve the compensation of our named executive officers for 2023 on an advisory basis; and | | |  4. |  To select the frequency of future advisory votes on executive compensation on an advisory basis. | | In addition, stockholders may be asked to conside","filed_date":"2024-04-26","accession":"0001193125-24-118116","full_text":"https://origin.rootz.global/static/filing/0001193125-24-118116.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"margin_pressure","strength":100,"match_count":16,"context":"entrance or expansion of these larger companies in the managed healthcare industry (including our customers who have in-sourced or who may choose to in-source healthcare services) could increase the competitive pressures we face and could limit our ability to maintain or increase our rates. Other competitors have proprietary technology that differentiates their product and service offerings from ours. Our competitor","filed_date":"2024-02-23","accession":"0001628908-24-000017","full_text":"https://origin.rootz.global/static/filing/0001628908-24-000017.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":88,"context":"unable to obtain, maintain and enforce the intellectual property rights on which our business depends, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. For additional information related to our intellectual property position see Part I - Item 1A. Risk Factors - Risks relating to Data Pr","filed_date":"2024-02-23","accession":"0001628908-24-000017","full_text":"https://origin.rootz.global/static/filing/0001628908-24-000017.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":49,"context":"27c5a9eb_681) Section 7.07Investment Company Act[83](#ib96d5842ae064c92a90a0a4127c5a9eb_676) Section 7.08Full Disclosure[83](#ib96d5842ae064c92a90a0a4127c5a9eb_671) Section 7.09Financial Condition No Material Adverse Effect[84](#ib96d5842ae064c92a90a0a4127c5a9eb_666) Section 7.10Tax Returns and Payments[85](#ib96d5842ae064c92a90a0a4127c5a9eb_661) Section 7.11Compliance with ERISA[85](#ib96d5842ae064c92a90a0a4127c5a9eb_6","filed_date":"2023-12-11","accession":"0001628908-23-000192","full_text":"https://origin.rootz.global/static/filing/0001628908-23-000192.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":15,"context":"rtion of our revenues from our largest partners. The loss, termination or renegotiation of our relationship or contract with any significant partner or multiple partners in the aggregate could have a material adverse effect on the Company's financial condition and results of operations. Note 11. Leases The Company enters into various office space, data center, and equipment lease agreements in conducting its normal busi","filed_date":"2023-11-02","accession":"0001628908-23-000165","full_text":"https://origin.rootz.global/static/filing/0001628908-23-000165.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":15,"context":"rtion of our revenues from our largest partners. The loss, termination or renegotiation of our relationship or contract with any significant partner or multiple partners in the aggregate could have a material adverse effect on the Company's financial condition and results of operations. Note 11. Leases The Company enters into various office space, data center, and equipment lease agreements in conducting its normal busi","filed_date":"2023-08-03","accession":"0001628908-23-000121","full_text":"https://origin.rootz.global/static/filing/0001628908-23-000121.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":15,"context":"rtion of our revenues from our largest partners. The loss, termination or renegotiation of our relationship or contract with any significant partner or multiple partners in the aggregate could have a material adverse effect on the Company's financial condition and results of operations. Note 11. Leases The Company enters into various office space, data center, and equipment lease agreements in conducting its normal busi","filed_date":"2023-05-04","accession":"0001628908-23-000066","full_text":"https://origin.rootz.global/static/filing/0001628908-23-000066.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":25,"context":"the Compensation Committees most recent review, the Compensation Committee determined that the risks arising from the Companys compensation policies and practices are not reasonably likely to have a material adverse effect on the Company.  |  |  |  |  |  |  |  | | |  |  |  Evolent Health, Inc. Proxy Statement 2023 |  |  |  43 |  | | [Table of Contents](#toc) COMPENSATION COMMITTEE REPORT  The Compensation Committee has","filed_date":"2023-04-28","accession":"0001193125-23-126887","full_text":"https://origin.rootz.global/static/filing/0001193125-23-126887.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"strategic_event","strength":100,"match_count":23,"context":"celerate its strategy through selective acquisitions.  During 2022 we announced and closed the acquisition of IPG, which builds on the breadth and depth of our service offerings. In November 2022, we signed a definitive agreement to acquire NIA, a specialty care management company, from Centene Corporation. This acquisition, which closed in January 2023, accelerates Evolents position as a leading multi-specialty independent p","filed_date":"2023-04-28","accession":"0001193125-23-126887","full_text":"https://origin.rootz.global/static/filing/0001193125-23-126887.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"margin_pressure","strength":100,"match_count":16,"context":"entrance or expansion of these larger companies in the managed healthcare industry (including our customers who have in-sourced or who may choose to in-source healthcare services) could increase the competitive pressures we face and could limit our ability to maintain or increase our rates. Other competitors have proprietary technology that differentiates their product and service offerings from ours. Our competitor","filed_date":"2023-02-24","accession":"0001628908-23-000029","full_text":"https://origin.rootz.global/static/filing/0001628908-23-000029.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":46,"context":"unable to obtain, maintain and enforce the intellectual property rights on which our business depends, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. For additional information related to our intellectual property position see Part I - Item 1A. Risk Factors - Risks relating to our bus","filed_date":"2023-02-24","accession":"0001628908-23-000029","full_text":"https://origin.rootz.global/static/filing/0001628908-23-000029.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"strategic_event","strength":100,"match_count":14,"context":"nt Activities On August 2, 2021, the Company, through a wholly owned subsidiary, entered into a definitive agreement for the Company to acquire Vital Decisions. On October 1, 2021, we consummated the acquisition of Vital Decisions for $46.5 million in cash and the issuance of 1.8 million shares of Class A common stock. Vital Decisions reports into Evolents specialty care management offering, New Century Health, and is consolidated i","filed_date":"2023-02-24","accession":"0001628908-23-000029","full_text":"https://origin.rootz.global/static/filing/0001628908-23-000029.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"strategic_event","strength":100,"match_count":18,"context":"ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022; and | | |  3. |  To approve the compensation of our named executive officers for 2021 on an advisory basis. | | In addition, stockholders may be asked to consider and vote upon any other matters that may properly be brought before the Annual Meeting and at any adjournments o","filed_date":"2022-04-29","accession":"0001193125-22-133588","full_text":"https://origin.rootz.global/static/filing/0001193125-22-133588.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"ai_adoption","strength":100,"match_count":14,"context":"alized; the growth and success of our partners, which is difficult to predict and is subject to factors outside of our control, including governmental funding reductions and other policy changes, enrollment numbers for our partners plans, premium pricing reductions, selection bias in at-risk membership and the ability to control and, if necessary, reduce health care costs; risks relating to our abili","filed_date":"2022-02-24","accession":"0001628908-22-000027","full_text":"https://origin.rootz.global/static/filing/0001628908-22-000027.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":43,"context":"unable to obtain, maintain and enforce the intellectual property rights on which our business depends, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. For additional information related to our intellectual property position see Part I - Item 1A. Risk Factors - Risks relating to our bus","filed_date":"2022-02-24","accession":"0001628908-22-000027","full_text":"https://origin.rootz.global/static/filing/0001628908-22-000027.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"strategic_event","strength":100,"match_count":27,"context":"s Executive Chairman, Frank continues to be a valuable thought partner for our management team and directors. Finally, in conjunction with Bruce Felts retirement from the Board in January 2021, I was appointed by our directors to serve as Evolents Lead Independent Director. Our entire Board would like to thank Bruce for his tremendous service; he has been an outstanding director. | | Consistent, two-way dialogue with our","filed_date":"2021-04-30","accession":"0001193125-21-145005","full_text":"https://origin.rootz.global/static/filing/0001193125-21-145005.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"ai_adoption","strength":100,"match_count":13,"context":"alized; the growth and success of our partners, which is difficult to predict and is subject to factors outside of our control, including governmental funding reductions and other policy changes, enrollment numbers for our partners plans, premium pricing reductions, selection bias in at-risk membership and the ability to control and, if necessary, reduce health care costs; risks relating to our abili","filed_date":"2021-02-26","accession":"0001628908-21-000026","full_text":"https://origin.rootz.global/static/filing/0001628908-21-000026.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":45,"context":"unable to obtain, maintain and enforce the intellectual property rights on which our business depends, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. For additional information related to our intellectual property position see Part I - Item 1A. Risk Factors - Risks relating to our bus","filed_date":"2021-02-26","accession":"0001628908-21-000026","full_text":"https://origin.rootz.global/static/filing/0001628908-21-000026.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":52,"context":"h representations and warranties shall have been true and correct in all material respects as of such earlier date); provided, that any representation or warranty that is qualified as to materiality, Material Adverse Effect or similar language is (or shall be) true and correct in all respects on such respective dates. (b) No Default or Event of Default has occurred and is continuing. (c) The execution, delivery and perf","filed_date":"2020-08-25","accession":"0001628908-20-000121","full_text":"https://origin.rootz.global/static/filing/0001628908-20-000121.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"strategic_event","strength":100,"match_count":18,"context":"y the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020; and | | | | | | | 3. | To approve the compensation of our named executive officers for 2019 on an advisory basis. | | In addition, stockholders may be asked to consider and vote upon any other matters that may properly be brought before the Annual Meeting and at any adjournments o","filed_date":"2020-04-29","accession":"0001628908-20-000046","full_text":"https://origin.rootz.global/static/filing/0001628908-20-000046.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"ai_adoption","strength":100,"match_count":15,"context":"| | | | the growth and success of our partners, which is difficult to predict and is subject to factors outside of our control, including governmental funding reductions and other policy changes, enrollment numbers for our partners plans (including in Florida), premium pricing reductions, selection bias in at-risk membership and the ability to control and, if necessary, reduce health care costs; | |","filed_date":"2020-03-02","accession":"0001628908-20-000032","full_text":"https://origin.rootz.global/static/filing/0001628908-20-000032.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":36,"context":"ble to obtain, maintain and enforce the intellectual property rights on which our business depends,  13 and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. For additional information related to our intellectual property position see Part I - Item 1A. Risk Factors - Risks relating to our bus","filed_date":"2020-03-02","accession":"0001628908-20-000032","full_text":"https://origin.rootz.global/static/filing/0001628908-20-000032.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":48,"context":"................................................. 61 Section 7.08 Full Disclosure ............................................................................. 61 Section 7.09 Financial Condition; No Material Adverse Effect ....................... 62 Section 7.10 Tax Returns and Payments........................................................... 62 Section 7.11 Compliance with ERISA......................................","filed_date":"2019-12-31","accession":"0001628908-19-000084","full_text":"https://origin.rootz.global/static/filing/0001628908-19-000084.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"strategic_event","strength":100,"match_count":13,"context":"fy the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December31, 2019; and | | | | | | | 3. | To approve the compensation of our named executive officers for 2018on an advisory basis. | | In addition, stockholders may be asked to consider and vote upon any other matters that may properly be brought before the Annual Meeting and at any adjournments or","filed_date":"2019-04-30","accession":"0001628908-19-000023","full_text":"https://origin.rootz.global/static/filing/0001628908-19-000023.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"ai_adoption","strength":100,"match_count":14,"context":"Healths performance-based contracts and products; | | | | | | | | the growth and success of our partners, which is difficult to predict and is subject to factors outside of our control, including enrollment numbers for our partners plans (including in Florida), premium pricing reductions, selection bias in at-risk membership and the ability to control and, if necessary, reduce health care costs, part","filed_date":"2019-02-28","accession":"0001628908-19-000006","full_text":"https://origin.rootz.global/static/filing/0001628908-19-000006.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":42,"context":"ncentrated with a single partner, Passport, which comprised 17.5%of our consolidated revenue for 2018. Recent changes in the way the state of Kentucky distributes federal Medicaid benefits have had a significant negative impact on Passport. See Risk factors- Recent rate changes in Kentucky have negatively impacted Passport, our largest partner in terms of revenue for 2018, and could significantly harm our business, financia","filed_date":"2019-02-28","accession":"0001628908-19-000006","full_text":"https://origin.rootz.global/static/filing/0001628908-19-000006.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"strategic_event","strength":100,"match_count":19,"context":"al year ending December31, 2018; | | | | | | | 3. | To approve an amendment to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan; | | | | | | | 4. | To approve the compensation of our named executive officers for 2017 on an advisory basis; and | | | | | | | 5. | To select the frequency of future advisory votes on executive compensation on an advisory basis. | | In addition, stockholders may be asked to c","filed_date":"2018-04-27","accession":"0001628908-18-000021","full_text":"https://origin.rootz.global/static/filing/0001628908-18-000021.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":32,"context":"unable to obtain, maintain and enforce the intellectual property rights on which our business depends, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. For additional information related to our intellectual property position see Part I - Item 1A. Risk Factors - Risks relating to our bus","filed_date":"2018-03-01","accession":"0001628908-18-000015","full_text":"https://origin.rootz.global/static/filing/0001628908-18-000015.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"strategic_event","strength":100,"match_count":7,"context":"ring Reorganization in 2015we contributed $2.4 millionto the plan. 14. Investments In and Advances to Affiliates Equity Method Investments During the years ended December31, 2017and 2016, the Company entered into joint venture agreements with various entities. At the time of the transactions, our economic interests in these entities ranged from 27%to 40%and our voting interests ranged from 28%to 40%. As ofDecember31, 2017, the Compa","filed_date":"2018-03-01","accession":"0001628908-18-000015","full_text":"https://origin.rootz.global/static/filing/0001628908-18-000015.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":21,"context":"o conduct the businesses in which they are engaged, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the business, properties, management, financial position, stockholders or members equity, results of operations or prospects of the Company, Evolent Health and the Companys other subsidiaries, tak","filed_date":"2017-08-14","accession":"0001193125-17-257355","full_text":"https://origin.rootz.global/static/filing/0001193125-17-257355.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":26,"context":"ch determination is made. The Company is not aware of any legal proceedings or claims as of June30, 2017, or December31, 2016, that the Company believes will have, individually or in the aggregate, a material adverse effect on the Companys financial position or result of operations.  24 Commitments Lease Commitments The Company has entered into lease agreements for its office locations in Arlington, Virginia, Chicago, I","filed_date":"2017-08-07","accession":"0001628908-17-000044","full_text":"https://origin.rootz.global/static/filing/0001628908-17-000044.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":22,"context":"o conduct the businesses in which they are engaged, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the business, properties, management, financial position, stockholders or members equity, results of operations or prospects of the Company, Evolent Health and the Companys other subsidiaries, tak","filed_date":"2017-06-28","accession":"0001193125-17-216535","full_text":"https://origin.rootz.global/static/filing/0001193125-17-216535.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":22,"context":"o conduct the businesses in which they are engaged, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the business, properties, management, financial position, stockholders or members equity, results of operations or prospects of the Company, Evolent Health and the Companys other subsidiaries, tak","filed_date":"2017-05-19","accession":"0001193125-17-176782","full_text":"https://origin.rootz.global/static/filing/0001193125-17-176782.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"strategic_event","strength":100,"match_count":24,"context":"xchange Act of 1934, as amended (the Exchange Act). In addition, as an emerging growth company, we are not required to conduct votes seeking approval, on an advisory basis, of the compensation of our named executive officers or the frequency with which such votes must be conducted. We will remain an emerging growth company until the earliest to occur of: (i) our reporting $1 billion or more in annual gross revenues; (ii","filed_date":"2017-04-27","accession":"0001628908-17-000015","full_text":"https://origin.rootz.global/static/filing/0001628908-17-000015.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":24,"context":"o conduct the businesses in which they are engaged, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the business, properties, management, financial position, stockholders or members equity, results of operations or prospects of the Company, Evolent Health and the Companys other subsidiaries, tak","filed_date":"2017-03-31","accession":"0001193125-17-106676","full_text":"https://origin.rootz.global/static/filing/0001193125-17-106676.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":27,"context":"unable to obtain, maintain and enforce the intellectual property rights on which our business depends, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. For additional information related to our intellectual property position see Part I - Item 1A. Risk Factors - Risks relating to our bus","filed_date":"2017-03-03","accession":"0001628908-17-000006","full_text":"https://origin.rootz.global/static/filing/0001628908-17-000006.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":25,"context":", the representations and warranties contained in the Merger Agreement are true and correct in all material respects (or, in the case of (i) any representation or warranty qualified by materiality or material adverse effect, and (ii) Section 3.27 thereunder, true and correct in all respects). (h)Pending Merger. The Company and Evolent Health expect that the respective transactions contemplated by the Merger Agreement wi","filed_date":"2016-09-14","accession":"0001628908-16-000062","full_text":"https://origin.rootz.global/static/filing/0001628908-16-000062.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"strategic_event","strength":100,"match_count":15,"context":"xchange Act of 1934, as amended (the Exchange Act). In addition, as an emerging growth company, we are not required to conduct votes seeking approval, on an advisory basis, of the compensation of our named executive officers or the frequency with which such votes must be conducted. We will remain an emerging growth company until the earliest to occur of: (i) our reporting $1 billion or more in annual gross revenues (ii)","filed_date":"2016-04-28","accession":"0001628908-16-000044","full_text":"https://origin.rootz.global/static/filing/0001628908-16-000044.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"risk_factor","strength":100,"match_count":26,"context":"unable to obtain, maintain and enforce the intellectual property rights on which our business depends, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. For additional information related to our intellectual property position see Part I - Item 1A. Risk Factors - Risks Relating to Our Bus","filed_date":"2016-02-29","accession":"0001628908-16-000030","full_text":"https://origin.rootz.global/static/filing/0001628908-16-000030.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"EVH","company":"Evolent Health, Inc.","exchange":"NYSE","sector":"Services-Management Services","signal_type":"ai_adoption","strength":100,"match_count":19,"context":"ded March 31, 2015, as compared to $20.1 million for the three months ended March 31, 2014. Platform and operations revenue increased by approximately $14.0 million or 110.7%, driven primarily by enrollment growth and the addition of two new partners to the platform and operations phase. As of March 31, 2015, we had seven partners with members on our platform as compared to five partners with members","filed_date":"2015-06-01","accession":"0001193125-15-208938","full_text":"https://origin.rootz.global/static/filing/0001193125-15-208938.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."}],"origin":{"leaf":"769339da78348248ed61c90f528ecb785050b3020b95cb98961fc6baf4e5ba2c","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"839cf6b8ce8445feb7da929b33f45176bd3faa31a0ba62eed83304686c0571f5","parent":null,"source":"signal_search","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":447,"hourly_limit":500,"remaining":53,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}